These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29530347)

  • 1. Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
    Wang P; Jiang L; Cao Y; Zhang X; Chen B; Zhang S; Huang K; Ye D; Zhou L
    Bioorg Med Chem; 2018 May; 26(8):1961-1970. PubMed ID: 29530347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.
    Huang K; Jiang L; Liang R; Li H; Ruan X; Shan C; Ye D; Zhou L
    Eur J Med Chem; 2019 Apr; 168():45-57. PubMed ID: 30798052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Design and Synthesis of
    Wang P; Jiang L; Cao Y; Ye D; Zhou L
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29890679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of 1,3,6,7-tetrahydroxyxanthone derivatives as phosphoglycerate mutase 1 inhibitors.
    Jiang K; Gao B; Yu J; Jiang L; Niu A; Jia Y; Meng T; Zhou L; Wang J
    Bioorg Med Chem Lett; 2021 Mar; 36():127820. PubMed ID: 33513389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.
    Hitosugi T; Zhou L; Elf S; Fan J; Kang HB; Seo JH; Shan C; Dai Q; Zhang L; Xie J; Gu TL; Jin P; Alečković M; LeRoy G; Kang Y; Sudderth JA; DeBerardinis RJ; Luan CH; Chen GZ; Muller S; Shin DM; Owonikoko TK; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Ye K; Boggon TJ; Kang S; He C; Chen J
    Cancer Cell; 2012 Nov; 22(5):585-600. PubMed ID: 23153533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Anthraquinone Analogues as Phosphoglycerate Mutase 1 Inhibitors.
    Huang K; Jiang L; Li H; Ye D; Zhou L
    Molecules; 2019 Feb; 24(5):. PubMed ID: 30818883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico-based identification of phytochemicals as novel human phosphoglycerate mutase 1 (PGAM1) inhibitors for cancer therapy.
    Kanwal N; Rasul A; Shah MA; Jabeen F; Sultana T
    Pak J Pharm Sci; 2021 Mar; 34(2(Supplementary)):665-670. PubMed ID: 34275800
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Fareed MM; El-Esawi MA; El-Ballat EM; Batiha GE; Rauf A; El-Demerdash FM; Alhumaydhi FA; Alsagaby SA
    Biomed Res Int; 2021; 2021():5515692. PubMed ID: 34195264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
    Jiang X; Sun Q; Li H; Li K; Ren X
    Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphoglycerate mutase controls serine pathway flux via 3-phosphoglycerate.
    Oslund RC; Su X; Haugbro M; Kee JM; Esposito M; David Y; Wang B; Ge E; Perlman DH; Kang Y; Muir TW; Rabinowitz JD
    Nat Chem Biol; 2017 Oct; 13(10):1081-1087. PubMed ID: 28805803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells.
    Qu J; Sun W; Zhong J; Lv H; Zhu M; Xu J; Jin N; Xie Z; Tan M; Lin SH; Geng M; Ding J; Huang M
    J Cell Biol; 2017 Feb; 216(2):409-424. PubMed ID: 28122957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1.
    Li X; Tang S; Wang QQ; Leung EL; Jin H; Huang Y; Liu J; Geng M; Huang M; Yuan S; Yao XJ; Ding J
    Front Pharmacol; 2017; 8():325. PubMed ID: 28611670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity evaluation of a novel series of xanthone derivatives.
    Guo N; Liu J; Qin L; Jiang D; You X; Lu K; Teng YO; Yu P
    J Asian Nat Prod Res; 2015; 17(4):377-83. PubMed ID: 25628155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
    Hitosugi T; Zhou L; Fan J; Elf S; Zhang L; Xie J; Wang Y; Gu TL; Alečković M; LeRoy G; Kang Y; Kang HB; Seo JH; Shan C; Jin P; Gong W; Lonial S; Arellano ML; Khoury HJ; Chen GZ; Shin DM; Khuri FR; Boggon TJ; Kang S; He C; Chen J
    Nat Commun; 2013; 4():1790. PubMed ID: 23653202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer.
    Huang K; Liang Q; Zhou Y; Jiang LL; Gu WM; Luo MY; Tang YB; Wang Y; Lu W; Huang M; Zhang SZ; Zhuang GL; Dai Q; Shen QC; Zhang J; Lei HM; Zhu L; Ye DY; Chen HZ; Zhou L; Shen Y
    Cell Metab; 2019 Dec; 30(6):1107-1119.e8. PubMed ID: 31607564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Biological Evaluation, and In Silico Studies of Novel Aminated Xanthones as Potential p53-Activating Agents.
    Lemos A; Gomes AS; Loureiro JB; Brandão P; Palmeira A; Pinto MMM; Saraiva L; Sousa ME
    Molecules; 2019 May; 24(10):. PubMed ID: 31121972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoglycerate mutase 1 in cancer: A promising target for diagnosis and therapy.
    Sharif F; Rasul A; Ashraf A; Hussain G; Younis T; Sarfraz I; Chaudhry MA; Bukhari SA; Ji XY; Selamoglu Z; Ali M
    IUBMB Life; 2019 Oct; 71(10):1418-1427. PubMed ID: 31169978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An allosteric PGAM1 inhibitor effectively suppresses pancreatic ductal adenocarcinoma.
    Wen CL; Huang K; Jiang LL; Lu XX; Dai YT; Shi MM; Tang XM; Wang QB; Zhang XD; Wang PH; Li HT; Ruan XX; Wang LW; Wang XJ; Wang Q; Lu W; Xiang XQ; Sun X; Xu YH; Lai LH; Zhan Q; Li HW; Peng CH; Chen J; Huang JY; Ye DY; Chen SJ; Chen Z; Li M; Fang Y; Shen BY; Zhou L
    Proc Natl Acad Sci U S A; 2019 Nov; 116(46):23264-23273. PubMed ID: 31662475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
    Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
    Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic and structural requirements for active site labeling of phosphoglycerate mutase by spiroepoxides.
    Evans MJ; Morris GM; Wu J; Olson AJ; Sorensen EJ; Cravatt BF
    Mol Biosyst; 2007 Jul; 3(7):495-506. PubMed ID: 17579775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.